Related references
Note: Only part of the references are listed.Quality control of house dust mite extracts by broad-spectrum profiling of allergen-related enzymatic activities
J. C. Vidal-Quist et al.
ALLERGY (2017)
Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life
Daniela Posa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Novel approaches and perspectives in allergen immunotherapy
H. J. Hoffmann et al.
ALLERGY (2017)
Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity
D. Hinz et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Effect of allergen-specific immunotherapy on CD4+ T cells
Erik Wambre
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Barrier Epithelial Cells and the Control of Type 2 Immunity
Hamida Hammad et al.
IMMUNITY (2015)
Glycoproteomic Analysis of Seven Major Allergenic Proteins Reveals Novel Post-translational Modifications
Adnan Halim et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo
Piotr S. Kowalski et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Allergen Immunotherapy and Tolerance
Tomokazu Matsuoka et al.
ALLERGOLOGY INTERNATIONAL (2013)
Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy
Kuan-Wei Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation
S. Post et al.
THORAX (2012)
Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation
S. Tourdot et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
Allergen-specific IgG antibody levels modify the relationship between allergen-specific IgE and wheezing in childhood
Adnan Custovic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Mechanisms of allergen-specific immunotherapy
Cezmi A. Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
From Allergen Genes to Allergy Vaccines
Rudolf Valenta et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Suppression of Th2-Driven Airway Inflammation by Allergen Immunotherapy Is Independent of B Cell and Ig Responses in Mice
Soheila Shirinbak et al.
JOURNAL OF IMMUNOLOGY (2010)
Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy
J. A. Asturias et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis
Peter S. Creticos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens
G Pittner et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies
N Mothes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Der p 1 and Der p 2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response
MJ Van Der Veen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)